Quantcast

Latest Medical statistics Stories

2014-05-15 23:14:53

Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May 15, 2014 ClinDatrix, Inc. (http://www.clindatrix.com) has signed collaboration agreements with six contract research organizations (CROs) from around the world to form a consortium that offers services for multinational clinical trials. On joint projects, consortium members will provide clinical trial project management, clinical...

2014-05-13 23:08:34

Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR), today announced that Aptiv Solutions, an ICON plc company leading the design and implementation of adaptive trials, has released ADDPLAN® DF 3.0, which incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials. Accurate...

2014-05-06 08:36:03

CLEVELAND, May 6, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics today announced that top-line interim data from its ongoing Phase II STOP-HF study will be presented in a late-breaking oral presentation at the European Society of Cardiology Heart Failure Congress (ESC-HF) taking place May 17 - 20, 2014 in Athens, Greece. The STOP-HF trial is a randomized, placebo-controlled, double-blinded study conducted at 15 centers in the United States to evaluate safety and efficacy of...

2014-04-30 08:31:35

ACRP Innovation Award is Latest for CRO Health Decisions DURHAM, N.C., April 30, 2014 /PRNewswire-iReach/ -- Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical devices companies, today announced that the Association of Clinical Research Professionals (ACRP) honored CEO Michael Rosenberg, MD, MPH, with its 2014 Innovation in Clinical Research Award at the ACRP Global Conference in San Antonio April 26. Photo -...

2014-04-29 12:33:17

Theorem Selects iMedNet(TM) EDC as Their eClinical Solution of Choice for Medical Device & Diagnostics Research Initiatives MINNETONKA, Minn., April 29, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in eClinical technology systems, is pleased to welcome Theorem Clinical Research into the iMedNet Partner Program. Theorem, one of the industry's leading contract research organizations, provides comprehensive clinical research and development...

2014-04-24 08:32:37

Latest Data Sweep from Large Subgroup of Patients Shows a Strong 50% Improvement in Overall Survival for ThermoDox® LAWRENCEVILLE, N.J., April 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that updated results from the 701 patient HEAT Study post-hoc analysis, as well as a review of the final study design of the Phase III OPTIMA Study, which both explore ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in...

2014-04-21 23:10:20

Verified Clinical Trials is proud to announce their presence at the 2014 Annual DIA meeting in San Diego, California. Verified Clinical Trials will discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality. Garden City, New York (PRWEB) April 21, 2014 Verified Clinical Trials (VCT) will again be an exhibitor at the the 2014 Annual DIA Meeting in San Diego. While at the conference,...

2014-04-16 08:34:21

Clinical Results Open Significant Market Opportunity for BioElectronics Corp. FREDERICK, Md., April 16, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced reports on preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. An abstract on the interim analysis of the osteoarthritis (OA) knee pain study has been accepted by...

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...

2014-04-07 12:34:11

LONDON, April 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013 Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013 SummaryGlobalData's clinical trial report, "Ventricular Arrhythmia Global Clinical Trials Review, H2, 2013" provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related